Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Tremont Mortgage Trust

27.4% sales growth and 8.96% return on equity

Tremont Mortgage Trust, a real estate investment trust (REIT), focuses on originating and investing in first mortgage loans secured by middle market and transitional commercial real estate in the United States.

Tremont Mortgage Trust sales growth this year is anticipated to be 46.9% and 0.5% for next year.

Year-on-year quarterly revenue growth grew by 8.4%, now sitting on 11.18M for the twelve trailing months.

Tremont Mortgage Trust’s sales growth for the next quarter is 27.4%. The company’s growth estimates for the current quarter and the next is 82.4% and 4.8%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.96%.

Tremont Mortgage Trust’s Stock Top and Bottom Yearly Value

Tremont Mortgage Trust’s stock is valued at $4.86 at 21:57 EST, way below its 52-week high of $6.86 and way higher than its 52-week low of $1.63.

Tremont Mortgage Trust’s Moving Average

Tremont Mortgage Trust’s worth is way higher than its 50-day moving average of $3.74 and way higher than its 200-day moving average of $3.08.

2. Digital Turbine, Inc.

84.2% sales growth and 38.39% return on equity

Digital Turbine, Inc., through its subsidiaries, provides media and mobile communication products and solutions for mobile operators, application advertisers, device original equipment manufacturers, and other third parties worldwide.

Digital Turbine, Inc. sales growth this year is expected to be 99.4% and 22.4% for next year.

Year-on-year quarterly revenue growth grew by 116.2%, now sitting on 205.27M for the twelve trailing months.

Digital Turbine, Inc.’s sales growth is a negative 0% for the current quarter and 84.2% for the next. The company’s growth estimates for the current quarter and the next is 220% and 220%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 38.39%.

Digital Turbine, Inc.’s Stock Top and Bottom Yearly Value

Digital Turbine, Inc.’s stock is valued at $42.95 at 21:57 EST, under its 52-week high of $45.92 and way higher than its 52-week low of $3.48.

Digital Turbine, Inc.’s Moving Average

Digital Turbine, Inc.’s worth is way higher than its 50-day moving average of $36.89 and way above its 200-day moving average of $24.04.

3. T

70.2% sales growth and 5.95% return on equity

T-Mobile US, Inc., through its subsidiaries, provides wireless services for branded postpaid and prepaid, and wholesale customers in the United States, Puerto Rico, and the United States Virgin Islands.

T sales growth this year is expected to be 50.3% and 15.1% for next year.

Year-on-year quarterly revenue growth grew by 74.2%, now sitting on 59.93B for the twelve trailing months.

T’s sales growth for the next quarter is 70.2%. The company’s growth estimates for the ongoing quarter and the next is a negative 43.7% and negative -42.7%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.95%.

T’s Stock Top and Bottom Yearly Value

T’s stock is valued at $131.23 at 21:57 EST, under its 52-week high of $134.24 and way higher than its 52-week low of $63.50.

T’s Moving Average

T’s value is above its 50-day moving average of $123.77 and way above its 200-day moving average of $113.13.

4. Salesforce

18% sales growth and 9.67% return on equity

salesforce.com, inc.

Salesforce sales growth this year is anticipated to be 23.5% and 20.2% for next year.

Year-on-year quarterly revenue growth grew by 20.1%, now sitting on 20.29B for the twelve trailing months.

Salesforce’s sales growth for the next quarter is 18%. The company’s growth estimates for the current quarter and the next is 13.6% and 7.1%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.67%.

Salesforce’s Stock Top and Bottom Yearly Value

Salesforce’s stock is valued at $222.42 at 21:57 EST, way under its 52-week high of $284.50 and way higher than its 52-week low of $115.29.

Salesforce’s Moving Average

Salesforce’s worth is below its 50-day moving average of $244.39 and above its 200-day moving average of $222.24.

5. Logitech International S.A.

20.7% sales growth and 46.66% return on equity

Logitech International S.A.

Logitech International S.A. sales growth this year is expected to be 37.8% and a negative 0.3% for next year.

Year-on-year quarterly revenue growth grew by 74.7%, now sitting on 3.66B for the twelve trailing months.

Logitech International S.A.’s sales growth is a negative 0% for the current quarter and 20.7% for the next. The company’s growth estimates for the ongoing quarter and the next is 20.2% and 21.4%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 46.66%.

Logitech International S.A.’s Stock Top and Bottom Yearly Value

Logitech International S.A.’s stock is valued at $87.32 at 21:57 EST, below its 52-week high of $95.71 and way higher than its 52-week low of $31.37.

Logitech International S.A.’s Moving Average

Logitech International S.A.’s worth is above its 50-day moving average of $85.45 and way higher than its 200-day moving average of $73.00.

6. CoStar Group, Inc.

14.4% sales growth and 6.48% return on equity

CoStar Group, Inc. provides information, analytics, and online marketplaces to the commercial real estate industry in the United States and the United Kingdom.

CoStar Group, Inc. sales growth this year is expected to be 17.8% and 15.7% for next year.

Year-on-year quarterly revenue growth grew by 20.6%, now sitting on 1.59B for the twelve trailing months.

CoStar Group, Inc.’s sales growth for the next quarter is 14.4%. The company’s growth estimates for the ongoing quarter and the next is a negative 14.2% and 8.6%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.48%.

CoStar Group, Inc.’s Stock Top and Bottom Yearly Value

CoStar Group, Inc.’s stock is valued at $893.39 at 21:57 EST, below its 52-week high of $939.00 and way above its 52-week low of $500.24.

CoStar Group, Inc.’s Moving Average

CoStar Group, Inc.’s value is higher than its 50-day moving average of $871.13 and way above its 200-day moving average of $794.40.

7. West Pharmaceutical Services, Inc.

15.6% sales growth and 19.44% return on equity

West Pharmaceutical Services, Inc. manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, Ireland, France, Other European countries, and internationally.

West Pharmaceutical Services, Inc. sales growth this year is expected to be 14.9% and 11.1% for next year.

Year-on-year quarterly revenue growth grew by 20.1%, now sitting on 2.04B for the twelve trailing months.

West Pharmaceutical Services, Inc.’s sales growth for the next quarter is 15.6%. The company’s growth estimates for the current quarter and the next is 36.6% and 18.8%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.44%.

West Pharmaceutical Services, Inc.’s Stock Top and Bottom Yearly Value

West Pharmaceutical Services, Inc.’s stock is valued at $263.98 at 21:57 EST, way under its 52-week high of $305.00 and way higher than its 52-week low of $124.53.

West Pharmaceutical Services, Inc.’s Moving Average

West Pharmaceutical Services, Inc.’s worth is below its 50-day moving average of $278.47 and higher than its 200-day moving average of $261.08.

8. Halozyme Therapeutics, Inc.

281.6% sales growth and 12.5% return on equity

Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, and internationally.

Halozyme Therapeutics, Inc. sales growth this year is anticipated to be 35% and 56.5% for next year.

Year-on-year quarterly revenue growth grew by 41.3%, now sitting on 199.56M for the twelve trailing months.

Halozyme Therapeutics, Inc.’s sales growth for the next quarter is 281.6%. The company’s growth estimates for the current quarter and the next is 316.7% and 1025%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.5%.

Halozyme Therapeutics, Inc.’s Stock Top and Bottom Yearly Value

Halozyme Therapeutics, Inc.’s stock is valued at $40.12 at 21:57 EST, below its 52-week high of $41.55 and way above its 52-week low of $12.71.

Halozyme Therapeutics, Inc.’s Moving Average

Halozyme Therapeutics, Inc.’s value is way higher than its 50-day moving average of $35.10 and way higher than its 200-day moving average of $28.82.

LEAVE A REPLY

Please enter your comment!
Please enter your name here